Infectious Disease
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 2,098,341 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,155,817 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 475,901 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 331,154 |
| Established patient office or other outpatient visit, 30-39 minutes | 324,947 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 191,244 |
| Established patient office or other outpatient visit, 20-29 minutes | 160,993 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 117,958 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 75,124 |
| Established patient office or other outpatient visit, 40-54 minutes | 64,956 |
| Critical care, first 30-74 minutes | 52,554 |
| Insertion of needle into vein for collection of blood sample | 49,724 |
| Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 41,565 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 37,120 |
| New patient office or other outpatient visit, 45-59 minutes | 28,070 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 25,981 |
| Removal of skin and tissue, 20.0 sq cm or less | 22,948 |
| Injection of drug or substance under skin or into muscle | 19,718 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 16,300 |
| Removal of tissue from wound, 20.0 sq cm or less | 16,002 |
| Refilling and maintenance of portable pump | 15,298 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14,915 |
| New patient office or other outpatient visit, 60-74 minutes | 14,145 |
| Established patient office or other outpatient visit, 10-19 minutes | 11,535 |
| Administration of influenza virus vaccine | 11,519 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 11,202 |
| Injection of additional new drug or substance into vein | 10,746 |
| Blood test, comprehensive group of blood chemicals | 10,608 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 10,377 |
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 9,390 |
| Hospital discharge day management, more than 30 minutes | 9,142 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 9,130 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 7,792 |
| Management of oxygen chamber therapy | 7,387 |
| New patient office or other outpatient visit, 30-44 minutes | 7,121 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 7,005 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 6,890 |
| Administration of chemotherapy into vein, 1 hour or less | 6,291 |
| Blood test, lipids (cholesterol and triglycerides) | 5,856 |
| Injection of drug or substance into vein | 5,356 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 5,305 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 5,263 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 5,042 |
| Hospital discharge day management, 30 minutes or less | 5,013 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 4,637 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 4,249 |
| Admn sarscov2 vacc 1 dose | 4,226 |
| Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | 4,098 |
| Blood test, basic group of blood chemicals (calcium, total) | 3,938 |
| Blood test, thyroid stimulating hormone (tsh) | 3,933 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 3,931 |
| Telephone medical discussion with physician, 11-20 minutes | 3,760 |
| Hemoglobin a1c level | 3,373 |
| Telephone medical discussion with physician, 21-30 minutes | 3,302 |
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 3,063 |
| Administration of chemotherapy into vein, each additional hour | 3,003 |
| Kerecis omega3, per square centimeter | 2,855 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 2,810 |
| Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | 2,763 |
| Measurement c-reactive protein for detection of infection or inflammation | 2,520 |
| Liver function blood test panel | 2,444 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 2,435 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 2,278 |
| Manual urinalysis test with examination using microscope, automated | 2,163 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 2,139 |
| Thyroxine (thyroid chemical), free | 2,076 |
| Removal of tissue from wound, each additional 20.0 sq cm | 1,941 |
| Advance care planning, first 30 minutes | 1,920 |
| Annual depression screening, 5 to 15 minutes | 1,840 |
| Vitamin d-3 level | 1,815 |
| Transitional care management services for problem of at least moderate complexity | 1,795 |
| Telephone medical discussion with physician, 5-10 minutes | 1,698 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 1,653 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 1,537 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 1,501 |
| Creatine kinase (cardiac enzyme) level, total | 1,471 |
| Administration of pneumococcal vaccine | 1,468 |
| Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | 1,430 |
| Interpretation and report of genetic testing | 1,428 |
| Magnesium level | 1,389 |
| Adm sarscv2 bvl 30mcg/.3ml a | 1,285 |
| Cyanocobalamin (vitamin b-12) level | 1,200 |
| Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | 1,199 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 1,173 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 1,128 |
| Transitional care management services for problem of high complexity | 1,110 |
| Urine microalbumin (protein) level | 1,067 |
| Phosphate level | 1,060 |
| Creatinine level to test for kidney function or muscle injury | 1,026 |
| Ferritin (blood protein) level | 1,014 |
| Administration of vaccine | 979 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 945 |
| Uric acid level, blood | 928 |
| Infusion into a vein for hydration, each additional hour | 908 |
| Iron level | 880 |
| Assessment of emotional or behavioral problems | 867 |
| Nursing facility discharge management, more than 30 minutes | 866 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 851 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 831 |
| Removal of tunneled central venous tube | 803 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).